BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11570567)

  • 21. Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica.
    Moya IA; Su Z; Honek JF
    Future Med Chem; 2009 Jul; 1(4):619-43. PubMed ID: 21426030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis.
    Jarrad AM; Debnath A; Miyamoto Y; Hansford KA; Pelingon R; Butler MS; Bains T; Karoli T; Blaskovich MA; Eckmann L; Cooper MA
    Eur J Med Chem; 2016 Sep; 120():353-62. PubMed ID: 27236016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructural alterations in organelles of parasitic protozoa induced by different classes of metabolic inhibitors.
    Rodrigues JC; de Souza W
    Curr Pharm Des; 2008; 14(9):925-38. PubMed ID: 18473841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of benzologues of Nitazoxanide and Tizoxanide: a comparative study of their in vitro broad-spectrum antiprotozoal activity.
    Navarrete-Vazquez G; Chávez-Silva F; Argotte-Ramos R; Rodríguez-Gutiérrez Mdel C; Chan-Bacab MJ; Cedillo-Rivera R; Moo-Puc R; Hernández-Nuñez E
    Bioorg Med Chem Lett; 2011 May; 21(10):3168-71. PubMed ID: 21397502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The activity of fexinidazole (HOE 239) against experimental infections with Trypanosoma cruzi, trichomonads and Entamoeba histolytica.
    Raether W; Seidenath H
    Ann Trop Med Parasitol; 1983 Feb; 77(1):13-26. PubMed ID: 6411009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative biochemistry of Giardia, Hexamita and Spironucleus: Enigmatic diplomonads.
    Lloyd D; Williams CF
    Mol Biochem Parasitol; 2014 Oct; 197(1-2):43-9. PubMed ID: 25448769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosupression, flagellated protozoa in the human airways and metronidazole: observations on the state of the art.
    Ribas A; Martínez-Girón R; Ponte-Mittelbrum C; Alonso-Cuervo R; Iglesias-Llaca F
    Transpl Int; 2007 Sep; 20(9):811-2. PubMed ID: 17617178
    [No Abstract]   [Full Text] [Related]  

  • 28. Tinidazole: a review of its antiprotozoal activity and therapeutic efficacy.
    Sawyer PR; Brogden RN; Pinder RM; Speight TM; Avery GS
    Drugs; 1976; 11(6):423-40. PubMed ID: 954609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA topoisomerases as targets for antiprotozoal therapy.
    Bakshi RP; Shapiro TA
    Mini Rev Med Chem; 2003 Sep; 3(6):597-608. PubMed ID: 12871162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of intestinal protozoan infections in children with MetroidazOLE Spofa].
    Giboda M; Hoffman F; Rimár P
    Cesk Pediatr; 1971 Feb; 26(2):88-9. PubMed ID: 5102117
    [No Abstract]   [Full Text] [Related]  

  • 31. Observations on the intestinal protozoa infecting man in Rhodesia.
    Goldsmid JM; Rogers S; Mahomed K
    S Afr Med J; 1976 Sep; 50(40):1547-50. PubMed ID: 988643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting DHFR in parasitic protozoa.
    Anderson AC
    Drug Discov Today; 2005 Jan; 10(2):121-8. PubMed ID: 15718161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Viruses of parasitic protozoa].
    Kasprzak W; Majewska AC
    Wiad Parazytol; 1995; 41(2):131-7. PubMed ID: 7571630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of parasitology laboratory results of a group of people older than 15 years of age in Kutahya].
    Akdemir C; Helvaci R
    Turkiye Parazitol Derg; 2007; 31(2):129-32. PubMed ID: 17594654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Snythesis and antiprotozoal activity of nitro derivatives of 2, 2'-biimidazole.
    Melloni P; Metelli R; Bassini DF; Confalonieri C; Logemann W; de Carneri I; Trane F
    Arzneimittelforschung; 1975 Jan; 25(1):9-14. PubMed ID: 167793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New derivatives of 5-nitroimidazole: synthesis and antiparasitic activity.
    Alcalde E; Maños L; Dinares I; Valls N; Elguero J; Escario JA; Martinez AR; Igea A; Osuna A; Ruiz-Perez LM
    Farmaco; 1989 Nov; 44(11):1095-107. PubMed ID: 2701965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tinidazole: a classical anaerobical drug with multiple potential uses nowadays].
    Granizo JJ; Pía Rodicio M; Manso FJ; Giménez MJ
    Rev Esp Quimioter; 2009 Jun; 22(2):106-14. PubMed ID: 19544102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic efficacy of new nitroimidazoles for experimental trichomoniasis, amebiasis, and trypanosomiasis.
    Cuckler AC; Malanga CM; Conroy J
    Am J Trop Med Hyg; 1970 Nov; 19(6):916-25. PubMed ID: 4321789
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on intestinal protozoa of domestic pigs in the Teheran area of Iran.
    Shieban F
    Br Vet J; 1971 Mar; 127(5):3-5. PubMed ID: 4323384
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial.
    Leitsch D
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):321-327. PubMed ID: 28910741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.